[1]
Briceño, E.D. and Naranjo-Gomez, A.L. 2020. Bevacizumab with adjuvant cyclophosphamide metronomical dose an alternative therapy in patients with recurrent gliomas. Archivos de Neurociencias. 23, 3 (May 2020), 19–27. DOI:https://doi.org/10.31157/an.v23i3.14.